Quantcast

Latest Mitral valve Stories

2014-06-11 08:29:37

Trendlines Medical and two portfolio companies of The Trendlines Group keep Trendlines on its award-winning path TEL AVIV, Israel, June 11, 2014 /PRNewswire/ -- Trendlines Medical [http://trendlines.com/medical ] received the Best Incubator award and two Trendlines portfolio companies received Best Start-up of the Year - Advanced Mem-Tech (Trendlines Agtech [http://trendlines.com/agtech ]) and MitrAssist (Trendlines Medical) - from Israel's Office of the Chief Scientist of the...

2014-05-27 12:30:37

PinnacleHealth Among Top Hospitals in United States to Offer Breakthrough Device for Patients with Mitral Valve Disease HARRISBURG, Pa., May 27, 2014 /PRNewswire/ -- Harold Lysle, Jr. of Carlisle, Pa., was considered too high risk for surgery due to the severity of his heart failure and other comorbidities. As his heart failure worsened, so did his quality of life. Harold suffered from a heart condition called mitral regurgitation, in which blood flows backward through a valve in his...

2014-05-12 23:06:30

Revolutionizing developments in biological tissue vales will drive the European transcatheter heart valve implantation market to over $1.7 Billion by 2020, Reports iData Research Vancouver, BC (PRWEB) May 12, 2014 According to a new report on the European Market for Cardiac Surgery Devices by iData Research (http://www.idataresearch.com), the leading global authority in medical device and pharmaceutical market research, the total European Cardiac Surgery Devices market is projected to...

2014-04-28 16:30:48

LONDON, April 28, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report: US Cardiac Surgery and Heart Valve Devices Markethttp://www.reportbuyer.com/pharma_healthcare/medical_devices/us_cardiac_surgery_heart_valve_devices_market.html The U.S. market for Cardiac Surgery and Heart Valve Device s will grow at a CAGR of 9.5% over theforecast period.The U.S. market for Cardiac Surgery and Heart Valve Device s is being sustained by the stability oftraditional...

2014-04-16 08:32:01

Funding Will Enable Initiation of Blinded, Randomized Clinical Trial and Expanded Commercialization of CARILLON® Mitral Contour System® KIRKLAND, Wash., April 16, 2014 /PRNewswire/ -- Cardiac Dimensions(®),( )Inc. today announced the completion of a $20 million financing. M. H. Carnegie & Co. and Lumira Capital led the financing as part of an international syndicate of institutional investors from Australia, the U.S. and Canada. The financing follows the company's completion...

2014-04-09 16:26:11

ROSEVILLE, Minn., April 9, 2014 /PRNewswire/ -- Tendyne Holdings, Inc. ("Tendyne"), a privately held clinical stage medical device company developing technologies for transcatheter mitral valve replacement, announced today that it has secured $25 million in an oversubscribed Series C financing led by Apple Tree Partners, along with Boulle Group members and other existing investors. Proceeds will be used for validation of Tendyne's novel Transcatheter Mitral Valve Implant to treat...

2014-03-26 12:29:52

Transcatheter Aortic Valve Replacement Devices Will See Rapid Adoption, But Are Unlikely to Match Success Seen in US and Europe, According to Findings from Decision Resources Group BURLINGTON, Mass., March 26, 2014 /PRNewswire/ -- Decision Resources Group finds that the Latin American market for heart valve devices will approach $200 million by 2022, with rapid growth driven largely by favorable demographics and the rising adoption of transcatheter heart valve (THV) products, including...

2014-02-19 12:28:22

Sets Stage for Expanded Adoption Of CARILLON® Mitral Contour System® KIRKLAND, Wash., Feb. 19, 2014 /PRNewswire/ -- Cardiac Dimensions(®),( )Inc. today announced that the Company's CARILLON(® )Mitral Contour System(® )has received German Neue Untersuchungs und Behandlungsmethoden (NUB) Status 1 approval across 120 leading hospitals in Germany, a decision from German regulators that may positively influence reimbursement from insurance companies for the costs of CARILLON...

2014-02-18 12:30:32

- Harpoon Has Raised More Than $300,000 in Competitive Grants and Award Funding in Less Than a Year - BALTIMORE, Feb. 18, 2014 /PRNewswire/ -- University of Maryland (UM) Ventures and Harpoon Medical, Inc. announced today that Harpoon Medical has obtained exclusive rights to a portfolio of technologies for cardiac valve repair from the University of Maryland, Baltimore (UMB). The licensed technology was developed in the Division of Cardiac Surgery at The University of Maryland School...

2014-01-30 12:28:23

DETROIT, Jan. 30, 2014 /PRNewswire/ -- For the first time in the U.S., doctors at Henry Ford Hospital have used an artificial heart valve designed for aortic valve replacement to repair a mitral valve that was narrowed with calcium buildup. And they did it all through a catheter. (Photo: http://photos.prnewswire.com/prnh/20140130/DE56074 ) Approximately 5 million people in the U.S. are diagnosed with heart valve disease each year. With an aging population that is often too frail...


Word of the Day
cruet
  • A vial or small glass bottle, especially one for holding vinegar, oil, etc.; a caster for liquids.
This word is Middle English in origin, and ultimately comes from the Old French, diminutive of 'crue,' flask.
Related